{"schema_version":"1","generated_at":"2026-10-29T02:15:28.738Z","data_as_of":null,"url":"https://www.findmykol.com/kol/shilpa-shahani","json_url":"https://www.findmykol.com/kol/shilpa-shahani/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"shilpa-shahani","name":"Shilpa Shahani","specialty":"Pediatric Hematology-Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"City Of Hope National Medical Center","institution_url":"https://www.findmykol.com/institution/city-of-hope","city":"Los Angeles","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1649594292","openalex":"A5070693731"},"summary":"Shilpa Shahani is an Oncology physician affiliated with City Of Hope National Medical Center. OpenAlex indexes 31 publications with 1,371 citations (h-index 14).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":31,"cited_by_count":1371,"h_index":14,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":3,"shown":3,"withheld":0,"rows":[{"payer":"Amgen Inc.","program_year":2022,"amount_usd":2335,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1649594292"},{"payer":"Amgen Inc.","program_year":2021,"amount_usd":3269,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1649594292"},{"payer":"JAZZ PHARMACEUTICALS INC.","program_year":2021,"amount_usd":167.39,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1649594292"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1649594292","source":"payments"},"publications":{"total":32,"shown":5,"withheld":27,"matched_by":"OpenAlex author record","recent":[{"title":"Impact of vein-to-vein time in patients with R/R LBCL treated with axicabtagene ciloleucel","year":2025,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2024013656","status":"verified"},{"title":"First-line consolidation with cemacabtagene ansegedleucel (cema-cel) in patients with large B-cell lymphoma (LBCL) and minimal residual disease (MRD) after response to standard therapy: The pivotal, randomized, open‑label Phase 2 ALPHA3 study","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-3730","status":"verified"},{"title":"Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor <scp>ECOG</scp> performance status with relapsed or refractory large B‐cell lymphoma after 2 or more lines of prior therapy","year":2024,"journal":"American Journal of Hematology","source_url":"https://doi.org/10.1002/ajh.27283","status":"verified"},{"title":"Minority Patients Receiving CAR T Therapy in the US between 2020−2025: A SEER-Based Projection on Racial Composition and Impact of Proximity to Authorized Treatment Centers","year":2024,"journal":"Biology of Blood and Marrow Transplantation","source_url":"https://doi.org/10.1016/j.jtct.2023.12.444","status":"verified"},{"title":"Abstract LB092: Novel tumor gene expression signatures predictive of outcome in large B cell lymphoma treated with CAR T cell therapy (axicabtagene ciloleucel)","year":2024,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.am2024-lb092","status":"verified"}],"source":"works"},"contact":{"address_1":"4650 W SUNSET BLVD","city":"Los Angeles","state":"CA","zip":"900276062","phone":"323-361-3550","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1649594292","source":"identity"},"similar":[{"name":"Erminia Massarelli","slug":"erminia-massarelli","institution":"City Of Hope National Medical Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/erminia-massarelli","json_url":"https://www.findmykol.com/kol/erminia-massarelli/profile.json"},{"name":"Swetha Thiruvengadam","slug":"swetha-thiruvengadam","institution":"City Of Hope National Medical Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/swetha-thiruvengadam","json_url":"https://www.findmykol.com/kol/swetha-thiruvengadam/profile.json"},{"name":"Yuman Fong","slug":"yuman-fong","institution":"City Of Hope National Medical Center","specialty":"Surgical Oncology","url":"https://www.findmykol.com/kol/yuman-fong","json_url":"https://www.findmykol.com/kol/yuman-fong/profile.json"},{"name":"Ravi Salgia","slug":"ravi-salgia","institution":"City Of Hope National Medical Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/ravi-salgia","json_url":"https://www.findmykol.com/kol/ravi-salgia/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":27}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2020-12-03","provider_certified":"2020-12-03","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}